KONINKLIJKE PHILIPS NVR- NY (PHG) Stock Fundamental Analysis
USA - NYSE:PHG - US5004723038
27.96 USD
-0.71 (-2.48%)
PHG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of PHG while its profitability can be described as average. PHG has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year PHG was profitable.
PHG had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PHG reported negative net income in multiple years.
Of the past 5 years PHG 4 years had a positive operating cash flow.
1.2 Ratios
PHG's Return On Assets of 0.61% is fine compared to the rest of the industry. PHG outperforms 72.87% of its industry peers.
PHG has a Return On Equity of 1.56%. This is in the better half of the industry: PHG outperforms 73.94% of its industry peers.
PHG has a better Return On Invested Capital (4.49%) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROIC | 4.49% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 0.91%, PHG is in the better half of the industry, outperforming 72.87% of the companies in the same industry.
The Operating Margin of PHG (6.11%) is better than 70.74% of its industry peers.
PHG's Operating Margin has declined in the last couple of years.
PHG has a Gross Margin of 43.85%. This is in the lower half of the industry: PHG underperforms 62.23% of its industry peers.
PHG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PHG is destroying value.
Compared to 1 year ago, PHG has less shares outstanding
The number of shares outstanding for PHG has been increased compared to 5 years ago.
PHG has a worse debt/assets ratio than last year.
2.2 Solvency
PHG has an Altman-Z score of 1.95. This is not the best score and indicates that PHG is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.95, PHG is in the better half of the industry, outperforming 60.64% of the companies in the same industry.
The Debt to FCF ratio of PHG is 19.41, which is on the high side as it means it would take PHG, 19.41 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of PHG (19.41) is better than 70.74% of its industry peers.
PHG has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHG is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.69, PHG is doing worse than 68.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Altman-Z | 1.95 |
ROIC/WACC0.67
WACC6.73%
2.3 Liquidity
A Current Ratio of 1.26 indicates that PHG should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.26, PHG is doing worse than 81.38% of the companies in the same industry.
PHG has a Quick Ratio of 1.26. This is a bad value and indicates that PHG is not financially healthy enough and could expect problems in meeting its short term obligations.
PHG has a worse Quick ratio (0.81) than 85.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 12.16% over the past year.
Measured over the past years, PHG shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.17% on average per year.
PHG shows a decrease in Revenue. In the last year, the revenue decreased by -0.81%.
PHG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.00% yearly.
EPS 1Y (TTM)12.16%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%0.5%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.14%
3.2 Future
PHG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.68% yearly.
Based on estimates for the next years, PHG will show a small growth in Revenue. The Revenue will grow by 3.65% on average per year.
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y12.68%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.65%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
PHG is valuated correctly with a Price/Earnings ratio of 16.64.
Compared to the rest of the industry, the Price/Earnings ratio of PHG indicates a rather cheap valuation: PHG is cheaper than 84.04% of the companies listed in the same industry.
PHG is valuated rather cheaply when we compare the Price/Earnings ratio to 25.89, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 15.69 indicates a correct valuation of PHG.
PHG's Price/Forward Earnings ratio is rather cheap when compared to the industry. PHG is cheaper than 84.04% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.59, PHG is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.64 | ||
| Fwd PE | 15.69 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PHG is valued cheaply inside the industry as 84.57% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, PHG is valued a bit cheaper than the industry average as 73.40% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 53.26 | ||
| EV/EBITDA | 12.7 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHG does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)70.05
PEG (5Y)N/A
EPS Next 2Y5.1%
EPS Next 3Y7.59%
5. Dividend
5.1 Amount
PHG has a Yearly Dividend Yield of 3.93%.
Compared to an average industry Dividend Yield of 1.69, PHG pays a better dividend. On top of this PHG pays more dividend than 98.94% of the companies listed in the same industry.
PHG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.93% |
5.2 History
The dividend of PHG decreases each year by -70.49%.
PHG has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-70.49%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
0.62% of the earnings are spent on dividend by PHG. This is a low number and sustainable payout ratio.
DP0.62%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
NYSE:PHG (11/17/2025, 3:27:33 PM)
27.96
-0.71 (-2.48%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners47.54%
Inst Owner Change-2.79%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap26.92B
Revenue(TTM)18.02B
Net Income(TTM)162.00M
Analysts74.81
Price Target31.77 (13.63%)
Short Float %0.29%
Short Ratio3.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.93% |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)-0.17%
PT rev (3m)1.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.89%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)-8.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.36%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-1.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.64 | ||
| Fwd PE | 15.69 | ||
| P/S | 1.29 | ||
| P/FCF | 53.26 | ||
| P/OCF | 21.03 | ||
| P/B | 2.23 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.7 |
EPS(TTM)1.68
EY6.01%
EPS(NY)1.78
Fwd EY6.37%
FCF(TTM)0.52
FCFY1.88%
OCF(TTM)1.33
OCFY4.75%
SpS21.6
BVpS12.55
TBVpS-2.05
PEG (NY)70.05
PEG (5Y)N/A
Graham Number21.78
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROCE | 5.69% | ||
| ROIC | 4.49% | ||
| ROICexc | 4.97% | ||
| ROICexgc | 16.33% | ||
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% | ||
| FCFM | 2.43% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Debt/EBITDA | 3.01 | ||
| Cap/Depr | 51.35% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 4 | ||
| Cash Conversion | 46.06% | ||
| Profit Quality | 267.9% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 1.95 |
F-Score8
WACC6.73%
ROIC/WACC0.67
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.16%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%0.5%
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y12.68%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.14%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.65%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.14%
EBIT Next 3Y21.01%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%
KONINKLIJKE PHILIPS NVR- NY / PHG FAQ
What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?
ChartMill assigns a fundamental rating of 4 / 10 to PHG.
What is the valuation status for PHG stock?
ChartMill assigns a valuation rating of 5 / 10 to KONINKLIJKE PHILIPS NVR- NY (PHG). This can be considered as Fairly Valued.
Can you provide the profitability details for KONINKLIJKE PHILIPS NVR- NY?
KONINKLIJKE PHILIPS NVR- NY (PHG) has a profitability rating of 4 / 10.
What are the PE and PB ratios of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?
The Price/Earnings (PE) ratio for KONINKLIJKE PHILIPS NVR- NY (PHG) is 16.64 and the Price/Book (PB) ratio is 2.23.
What is the expected EPS growth for KONINKLIJKE PHILIPS NVR- NY (PHG) stock?
The Earnings per Share (EPS) of KONINKLIJKE PHILIPS NVR- NY (PHG) is expected to grow by 0.24% in the next year.